Darya-Varia Laboratoria Tbk
PT Darya-Varia Laboratoria Tbk manufactures and trades pharmaceutical products and cosmetics in Indonesia. It operates in four segments: Prescription Drugs, Consumer Health Products, Export and Toll Manufacturing Services, and Services. The company offers prescription products in various areas of cardiology, analgesics, gastro-hepatology, dermamedic, somatic, cough and cold, antibiotic, women hea… Read more
Darya-Varia Laboratoria Tbk (DVLA) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of June 2025: 0.063x
Based on the latest financial reports, Darya-Varia Laboratoria Tbk (DVLA) has a cash flow conversion efficiency ratio of 0.063x as of June 2025.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Rp94.03 Billion) by net assets (Rp1.49 Trillion). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Darya-Varia Laboratoria Tbk - Cash Flow Conversion Efficiency Trend (2000–2024)
This chart illustrates how Darya-Varia Laboratoria Tbk's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
Darya-Varia Laboratoria Tbk Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Darya-Varia Laboratoria Tbk ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Eastern Power Group Public Company Limited
BK:EP
|
0.002x |
|
Ikena Oncology Inc
NASDAQ:IKNA
|
-0.030x |
|
Chicago Rivet & Machine Co
NYSE MKT:CVR
|
0.032x |
|
Jasper Mining Corporation
PINK:JAMGF
|
-0.001x |
|
AUREA SA INH. EO 120
F:94P
|
N/A |
|
North Energy ASA
OL:NORTH
|
-0.013x |
|
Peloton Minerals Corporation
OTCQB:PMCCF
|
0.185x |
|
ThroughTek Co., Ltd.
TWO:6565
|
-0.053x |
Annual Cash Flow Conversion Efficiency for Darya-Varia Laboratoria Tbk (2000–2024)
The table below shows the annual cash flow conversion efficiency of Darya-Varia Laboratoria Tbk from 2000 to 2024.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | Rp1.45 Trillion | Rp331.76 Billion | 0.229x | +194.51% |
| 2023-12-31 | Rp1.40 Trillion | Rp109.19 Billion | 0.078x | +779.46% |
| 2022-12-31 | Rp1.40 Trillion | Rp-16.06 Billion | -0.011x | -103.63% |
| 2021-12-31 | Rp1.38 Trillion | Rp435.33 Billion | 0.315x | +292.32% |
| 2020-12-31 | Rp1.33 Trillion | Rp106.58 Billion | 0.080x | -61.49% |
| 2019-12-31 | Rp1.31 Trillion | Rp272.54 Billion | 0.209x | +840.57% |
| 2018-12-31 | Rp1.20 Trillion | Rp26.63 Billion | 0.022x | -89.27% |
| 2017-12-31 | Rp1.12 Trillion | Rp230.74 Billion | 0.207x | +19.03% |
| 2016-12-31 | Rp1.08 Trillion | Rp187.48 Billion | 0.174x | -21.06% |
| 2015-12-31 | Rp973.52 Billion | Rp214.17 Billion | 0.220x | +102.73% |
| 2014-12-31 | Rp962.43 Billion | Rp104.44 Billion | 0.109x | -7.18% |
| 2013-12-31 | Rp914.70 Billion | Rp106.93 Billion | 0.117x | -17.47% |
| 2012-12-31 | Rp841.55 Billion | Rp119.21 Billion | 0.142x | +42.19% |
| 2011-12-31 | Rp727.92 Billion | Rp72.52 Billion | 0.100x | -51.14% |
| 2010-12-31 | Rp640.60 Billion | Rp130.61 Billion | 0.204x | +1888.91% |
| 2009-12-31 | Rp554.92 Billion | Rp5.69 Billion | 0.010x | -96.31% |
| 2008-12-31 | Rp507.85 Billion | Rp141.00 Billion | 0.278x | +37.27% |
| 2007-12-31 | Rp462.23 Billion | Rp93.49 Billion | 0.202x | +41.12% |
| 2006-12-31 | Rp412.31 Billion | Rp59.09 Billion | 0.143x | -24.56% |
| 2005-12-31 | Rp390.60 Billion | Rp74.21 Billion | 0.190x | +8.87% |
| 2004-12-31 | Rp319.03 Billion | Rp55.67 Billion | 0.174x | -29.75% |
| 2003-12-31 | Rp273.48 Billion | Rp67.93 Billion | 0.248x | -8.28% |
| 2002-12-31 | Rp227.09 Billion | Rp61.50 Billion | 0.271x | +12.46% |
| 2001-12-31 | Rp163.55 Billion | Rp39.39 Billion | 0.241x | +28.10% |
| 2000-12-31 | Rp170.17 Billion | Rp31.99 Billion | 0.188x | -- |